PATENT CLAIM ANALYSIS

Application Number: 15955523
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "265100"]

Abstract:
The present invention relates to a pyrrolopyrimidine compound as TLR7 agonist, and particularly relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation process thereof, a pharmaceutical composition containing such compounds and use thereof for manufacturing a medicament against viral infection.

Claim (Index 31):
A pharmaceutical composition, comprising the compound according to  claim 17  or the pharmaceutically acceptable salt thereof in a therapeutically effective amount and one or more pharmaceutically acceptable carriers or excipients.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15503977', '15319726', '12334371', '13470122', '16096848']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7923037620337878
- 35 USC 102 Novelty (BERT): 0.5592973588516363
- Combined Prediction Score: 0.7690031217155726
- Mean Citation Score: 343.2720819999999
- Max Citation Score: 457.27234
- Similarity Product: 339.4822788209224

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test